Drug intelligence / Profile preview

Duozinal

Development stage
Unknown
Lead developer
Aflofarm
Modality
Small Molecules
Administration
Oral
01

Overview

Duozinal is an over-the-counter (OTC) anti-allergic combination medication developed by the Polish pharmaceutical company Aflofarm. It is formulated as an oral syrup containing cetirizine dihydrochloride, a second-generation, selective peripheral histamine H1 receptor antagonist, and calcium chloride dihydrate. Cetirizine provides relief from allergic symptoms by blocking the action of histamine at the H1 receptor, thereby reducing symptoms such as sneezing, nasal itching, and hives. Calcium is included in the formulation as a supplementary component. The product is indicated for adults and children aged 2 years and older for the treatment of nasal and ocular symptoms associated with seasonal and chronic allergic rhinitis, as well as chronic idiopathic urticaria. It is marketed as a unique combination formulation in the European market.

Brand names
Duozinal
Other names
cetirizine + calcium syrup
02

Targets

HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Duozinal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duozinal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call